OBJECTIVE: The study was undertaken to determine the pathologic basis of subtle abnormalities in magnetization transfer ratio (MTR) and diffusion tensor imaging (DTI) parameters observed in normal-appearing white matter (NAWM) in multiple sclerosis brains. METHODS: Brain tissues were obtained through a rapid postmortem protocol that included in situ magnetic resonance imaging (MRI). Four types of MRI-defined regions of interest (ROIs) were analyzed: (1) regions that were abnormal on all images (T2T1MTR lesions); (2) NAWM regions with slightly abnormal MTR located close to white matter lesions (sa-WM Close); (3) NAWM regions with slightly abnormal MTR located far from lesions (sa-WM Far); and (4) NAWM regions with normal MTR (NAWM). Immunohistochemical analysis for each ROI comprised immunostaining for myelin, axonal markers, activated microglia/macrophages, astrocytes, plasma proteins, and blood vessels. RESULTS: Forty-eight ROIs from 4 secondary progressive MS brains were analyzed. sa-WM Close ROIs were associated with significantly more axonal swellings. There were more enlarged major histocompatibility complex II(+) microglia and macrophages detected in sa-WM Far, sa-WM Close, and T2T1MTR lesions than in NAWM. Across all ROIs, MTR and DTI measures were moderately correlated with myelin density, axonal area, and axonal counts. Excluding T2T1MTR lesions from analysis revealed that MTR and DTI measures in nonlesional white matter (WM) were correlated with activated microglia, but not with axonal or myelin integrity. INTERPRETATION: The pathologic substrates for MRI abnormalities in NAWM vary based on distance from focal WM lesions. Close to WM lesions, axonal pathology and microglial activation may explain subtle MRI changes. Distant from lesions, microglial activation associated with proximity to cortical lesions might underlie MRI abnormalities.
OBJECTIVE: The study was undertaken to determine the pathologic basis of subtle abnormalities in magnetization transfer ratio (MTR) and diffusion tensor imaging (DTI) parameters observed in normal-appearing white matter (NAWM) in multiple sclerosis brains. METHODS: Brain tissues were obtained through a rapid postmortem protocol that included in situ magnetic resonance imaging (MRI). Four types of MRI-defined regions of interest (ROIs) were analyzed: (1) regions that were abnormal on all images (T2T1MTR lesions); (2) NAWM regions with slightly abnormal MTR located close to white matter lesions (sa-WM Close); (3) NAWM regions with slightly abnormal MTR located far from lesions (sa-WM Far); and (4) NAWM regions with normal MTR (NAWM). Immunohistochemical analysis for each ROI comprised immunostaining for myelin, axonal markers, activated microglia/macrophages, astrocytes, plasma proteins, and blood vessels. RESULTS: Forty-eight ROIs from 4 secondary progressive MS brains were analyzed. sa-WM Close ROIs were associated with significantly more axonal swellings. There were more enlarged major histocompatibility complex II(+) microglia and macrophages detected in sa-WM Far, sa-WM Close, and T2T1MTR lesions than in NAWM. Across all ROIs, MTR and DTI measures were moderately correlated with myelin density, axonal area, and axonal counts. Excluding T2T1MTR lesions from analysis revealed that MTR and DTI measures in nonlesional white matter (WM) were correlated with activated microglia, but not with axonal or myelin integrity. INTERPRETATION: The pathologic substrates for MRI abnormalities in NAWM vary based on distance from focal WM lesions. Close to WM lesions, axonal pathology and microglial activation may explain subtle MRI changes. Distant from lesions, microglial activation associated with proximity to cortical lesions might underlie MRI abnormalities.
Authors: H Vrenken; J J G Geurts; D L Knol; C H Polman; J A Castelijns; P J W Pouwels; F Barkhof Journal: AJNR Am J Neuroradiol Date: 2006-10 Impact factor: 3.825
Authors: M Rovaris; M Bozzali; G Santuccio; A Ghezzi; D Caputo; E Montanari; A Bertolotto; R Bergamaschi; R Capra; G Mancardi; V Martinelli; G Comi; M Filippi Journal: Brain Date: 2001-12 Impact factor: 13.501
Authors: V L Stevenson; G J Parker; G J Barker; K Birnie; P S Tofts; D H Miller; A J Thompson Journal: J Neurol Sci Date: 2000-09-15 Impact factor: 3.181
Authors: Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli Journal: Neurology Date: 2015-12-16 Impact factor: 9.910
Authors: Michael Amann; Athina Papadopoulou; Michaela Andelova; Stefano Magon; Nicole Mueller-Lenke; Yvonne Naegelin; Christoph Stippich; Ernst Wilhelm Radue; Oliver Bieri; Ludwig Kappos; Till Sprenger Journal: J Neurol Date: 2015-06-05 Impact factor: 4.849
Authors: B M Bettcher; J M Gelfand; S R Irani; J Neuhaus; S Forner; C P Hess; M D Geschwind Journal: Eur J Neurol Date: 2014-07-01 Impact factor: 6.089
Authors: Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith Journal: Magn Reson Med Date: 2012-08-20 Impact factor: 4.668
Authors: Benedetta Bodini; Mara Cercignani; Ahmed Toosy; Nicola De Stefano; David H Miller; Alan J Thompson; Olga Ciccarelli Journal: Hum Brain Mapp Date: 2013-04-24 Impact factor: 5.038